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A dynamic cycle of O-linked GlcNAc (O-GlcNAc) addition
and removal is catalyzed by O-GlcNAc transferase and
O-GlcNAcase, respectively, in a process that serves as the final
step in a nutrient-driven “hexosamine-signaling pathway.”
Evidence points to a role for O-GlcNAc cycling in diabetes and
insulin resistance. We have used Drosophila melanogaster to
determine whether O-GlcNAc metabolism plays a role in mod-
ulating Drosophila insulin-like peptide (dilp) production and
insulin signaling. We employed transgenesis to either overex-
press or knock down Drosophila Ogt(sxc) and Oga in insulin-
producing cells (IPCs) or fat bodies using the GAL4-UAS sys-
tem. Knockdown of Ogt decreased Dilp2, Dilp3, and Dilp5
production, with reduced body size and decreased phosphory-
lation of Akt in vivo. In contrast, knockdown of Oga increased
Dilp2, Dilp3, and Dilp5 production, increased body size, and
enhanced phosphorylation of Akt in vivo. However, knock-
down of either Ogt(sxc) or Oga in the IPCs increased the he-
molymph carbohydrate concentration. Furthermore, phos-
phorylation of Akt stimulated by extraneous insulin in an ex
vivo cultured fat body of third instar larvae was diminished in
strains subjected to IPC knockdown of Ogt or Oga. Knock-
down of O-GlcNAc cycling enzymes in the fat body dramati-
cally reduced neutral lipid stores. These results demonstrate
that altered O-GlcNAc cycling in Drosophila IPCs modulates
insulin production and influences the insulin responsiveness
of peripheral tissues. The observed phenotypes in O-GlcNAc
cycling mimic pancreatic -cell dysfunction and glucose toxic-
ity related to sustained hyperglycemia in mammals.
Like protein phoshophorylation, the dynamic addition and
removal of O-linked GlcNAc (O-GlcNAc)3 in over 500 intra-
cellular proteins is a key regulator of nuclear and cytoplasmic
protein activity (1, 2). The O-GlcNAc modification is partly
driven by the levels of UDP-GlcNAc derived from the hexosa-
mine biosynthetic pathway. This pathway is a nutrient-sens-
ing pathway implicated in cellular signaling and insulin resis-
tance. Two enzymes mediate cycling of O-GlcNAc: a
glycosyltransferase (O-GlcNAc transferase; OGT) and a hex-
osaminidase (O-GlcNAcase; OGA). OGT-related sequences
have been identified from Archaea to humans (3, 4). In plants,
the OGT homolog Spindly and Secret Agent are involved in
development (5, 6). These evolutionarily conserved proteins
share a conserved structure. OGT contains tetratricopeptide
repeats at the N terminus and a catalytic domain at the C ter-
minus composed of Rossman-like folds. OGA, originally iden-
tified as meningioma-expressed autoantigen (termed
MGEA5), is a member of the family 84 glycoside hydrolases
(7). OGA is also highly conserved in eukaryotic evolution
from insects to humans. In mammals, the MGEA5 gene en-
codes at least two alternatively spliced transcripts. The longer
of these was originally designated OGA and has a C-terminal
MYST family histone acetyltransferase-like domain (8–10).
The N-terminal “hyaluronidase” domain has been proposed
to be the catalytic site for OGA glycosidase activity and con-
forms to the Triosephosphate isomerase-barrel fold that typi-
fies this class of glycosylhydrolases (1, 2).
Several independent lines of evidence point to a role for
O-GlcNAc modification in diabetes and insulin resistance (11,
12). Overexpression of the OGT in muscle and fat leads to
insulin resistance and hyperleptinemia (13). In addition, the
O-GlcNAcase was recently shown to be a type 2 diabetes sus-
ceptibility gene associated with obesity in the Mexican-Amer-
ican population (14). Diabetes results from the failure of insu-
lin production from the pancreatic -cells and from insulin
resistance in the peripheral tissues including liver, muscle,
and white adipose tissue. Interestingly, transcripts encoding
OGT are enriched in the pancreatic -cells (15). Taken to-
gether, these studies suggest that nutrient-driven
O-GlcNAcylation of proteins through hexosamine biosyn-
thetic pathway in the -cells could alter insulin production.
However, a suitable whole animal model in which to examine
this problem has been lacking.
Development of appropriate mouse knock-out models of
the enzymes of hexosamine signaling has proven difficult be-
cause the pathway is essential in mammals. Knock-outs of
OGT are embryonic and stem cell lethal (16), and conditional
knock-outs of OGT in various tissues are complicated by in-
duced tissue-specific lethality (17). Overexpression of OGA
induces a mitotic exit phenotype (18), suggesting that it too
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may perform essential functions. We originally identified
Caenorhabditis elegansOGT and OGA and have shown that
knock-outs of ogt-1 and oga-1 in the nematode, although via-
ble and fertile, have striking effects on insulin-like signaling
and macronutrient storage (19, 20).
Our previous studies, and those of others, have demon-
strated that many Drosophila proteins are modified by
O-GlcNAc, suggesting that this modification may play a role
in signaling in the fly model (21, 22). However, it is not clear
how the cycling of O-GlcNAc on these target proteins is regu-
lated by nutritional cues. Recently in Drosophila, ogt was
identified as sxc (super sex combs), a gene regulating the ho-
meotic genes that establish the adult body plan in the fly (23,
24). Flies harboring the loss of function alleles of ogt/sxc show
arrested development. Null alleles of ogt/sxc arrest at third
instar larvae or earlier and are thus not suitable for metabolic
studies of the kind envisioned here.
Despite these limitations, the fly provides an excellent, un-
explored genetic model for examining the influence of the
hexosamine biosynthetic pathway on insulin signaling be-
cause the insulin-signaling pathway in Drosophila is highly
conserved and similar to the mammalian insulin-signaling
pathway (25, 26). The Drosophila genome contains several
Drosophila insulin-like peptide genes (dilp) with significant
homology to mouse and human insulin (25). Drosophila has
insulin-producing cells (IPCs) in morphologically discrete
regions of the brain (27). Ablation of these IPCs in the fly re-
sults in elevation of trehalose and glucose levels in the hemo-
lymph similar to the hyperglycemia observed in mammalian
diabetes mellitus (28, 29). Deletion of dilp1–5 causes delayed
growth and increased carbohydrate levels in the hemolymph
(30). Additionally, the Drosophila fat body is an organ that
functions similarly to both mammalian liver and white adi-
pose tissue (31).
In this study, we have explored the possibility that
O-GlcNAc cycling in the insulin-producing cells is a key me-
diator of insulin production regulating the insulin-signaling
pathway in the fly. We established several transgenic loss or
gain of function models of sxc/ogt (CG10392) or oga
(CG5871), using the GAL4-UAS system. Using these trans-
genic flies, we found that tissue-specific, O-GlcNAc modula-
tion altered insulin secretion from the IPCs, carbohydrate
content in the hemolymph, body size, and insulin sensitivity.
These phenotypes are consistent with insulin resistance in
response to altered O-GlcNAc cycling and with associated
changes in glucose-insulin homeostasis.
EXPERIMENTAL PROCEDURES
Fly Stocks and Culturing for Experiments—The dILP2-
GAL4 line was obtained from Dr. Eric Rulifson (University of
California, San Francisco). The UAS-OGT line that contains
Myc epitope tag in the N terminus (UAS-Myc-OGT) was
made by P-element-mediated transformation. The Lsp2-
GAL4 line (stock 6357) was obtained from Bloomington Stock
center. UAS-RNAi lines of Ogt (stock 18611) and Oga (stock
41822) were obtained from Vienna Drosophila RNAi Center.
w1118 crossed with dILP2-GAL4 or Lsp2-GAL4 was used as
control as indicated. The stocks were maintained at 25 °C un-
der constant humidity using standard sugar/yeast medium. In
some experiments, adult flies were starved on 1.3% agar for
6 h.
Immunostaining—Brains of third instar larvae were dis-
sected and fixed for 1 h with 4% paraformaldehyde in PBS at
25 °C, and then tissues were treated with 0.3% Triton X-100
and 5% normal goat serum in PBS for 4 h at 4 °C, as a block
for nonspecific antibody binding. Affinity-purified rabbit anti-
Drosophila insulin (DILP) antiserum (gift from Dr. Eric Rulif-
son) was used at 1:200 and incubated with samples at 4 °C for
overnight and then incubated with Alexa Fluor 546 goat anti-
rabbit as a secondary antibody. To evaluate cell toxicity in
IPCs, brains were treated with TUNEL reaction solution from
an in situ cell death detection kit (Roche Applied Science) for
1 h at 37 °C. For positive control, 1 unit of DNase I (Invitro-
gen) was incubated for 15 min at 37 °C prior to TUNEL reac-
tion. For staining of nucleus, the brains were stained with
DAPI for 15 min at 25 °C. Confocal imaging was carried out
on an LSM 410 microscope (Zeiss).
Evaluation of Body Size—Individual adult flies were
weighed three times for accuracy. To compare the body size
of third instar larvae, larvae were collected according to the
protocol described previously (28). The larvae were digitally
photographed at 6.5 magnification. We used the iVision
Scientific Image Processing software (Biovision Technology,
Exton, PA) to measure the pixel area of whole bodies. We
evaluated the relative size values compared with control
larvae.
Quantitative Real Time PCR—Total RNA from whole bod-
ies of wandering third instar larvae was extracted using the
RNeasy mini kit (Qiagen) and reverse transcribed by the Su-
perscript III system (Invitrogen). Quantitative PCR was per-
formed using the 7900HT fast real time PCR system (Applied
Biosystems, Foster City, CA). The primers for quantitative
real time PCR were as follows: dilp2F, CCTGCAGTTTGTC-
CAGGAGTTC; dilp2R, TCGCAGCGGTTCCGATAT;
dilp3F, CAAACTGCCCGAAACTCTCT; dilp3R, CTCTTG-
GTCATTGCGTTGAA; dilp5F, AATTCAATGTTCGC-
CAAACG; dilp5R, CGCCAAGTGGTCCTCATAAT;
Actin42F, CCATGTACCCGGGAATCG; and Actin42R,
GAGCCAACGCCGTGATTT.
Measurement of Hemolymph Carbohydrate—Hemolymph
samples were collected as described (27). Carbohydrate levels
were evaluated by Dionex high performance anion exchange
equipped with a pulsed amperometric detector (model PAD
2) and pellicular anion exchange column (PA 10, 4  250
mm). The concentration of each carbohydrate levels was de-
termined by the absolute value of the area of the peak at
standard sample.
Western Blot Analysis—Whole bodies of 4-day-old adult
flies were isolated in the protein extraction buffer (Pierce).
Whole bodies or dissected fat bodies of wandering third instar
larvae were isolated in the Drosophila homogenate buffer as
described (29). Total proteins were separated by SDS-PAGE
and then incubated with phospho-Drosophila Akt (Ser-505)
antibody or Akt antibody (Cell Signaling, Danvers, MA) as
primary antibody, and then membranes were incubated with
Blocking O-GlcNAc Cycling Perturbs Insulin Homeostasis
DECEMBER 3, 2010 • VOLUME 285 • NUMBER 49 JOURNAL OF BIOLOGICAL CHEMISTRY 38685
IR800-labeled secondary antibodies (LI-COR). The blots were
visualized using an imaging scanner (LI-COR).
Ex Vivo Culture of Fat Body—Fat bodies of wandering third
instar larvae were dissected and cultured referring to the pro-
tocol (32). In brief, fat bodies were dissected in the Schnei-
der’s medium and incubated in the Schneider’s medium for
4 h at 25 °C, and then 1 g/ml insulin was administrated in
the medium and cultured for another 15 min. Isolated pro-
teins were separated by SDS-PAGE and immunoblotted with
Drosophila-specific p-Akt antibody (Ser-505) or Akt antibody.
Statistical Analysis—The values are expressed as the
means  S.E., unless otherwise stated. The mean values were
compared using Student’s t test. An asterisk in the figures in-
dicates a significant difference from control (p  0.05).
RESULTS
Altered O-GlcNAc Cycling in IPCs Influences Growth—We
analyzed the effects of IPC-specific knockdown of endoge-
nous ogt or oga by using the same driver, dILP2-GAL4, as de-
scribed above to express a UAS-RNAi hairpin directed against
ogt or oga (dILP2GAL4/;UAS-dOGTRNAi/ and
dILP2GAL4/;UAS-dOGARNAi/). This dILP2-GAL4 line
has been extensively used to target the IPCs in the fly and was
previously used to ablate the median neurosecretory cells
(28). The RNAi construct targeted to ogt was tested for its
effectiveness using a strong tub-Gal4, which phenocopied Sxc
null alleles by producing no adult offspring. Previous studies
have shown that ablation of IPCs induces a decrease in the
body size, and overexpression of dilp2 rescues the body size
(28). We analyzed the changes in body size in third instar lar-
vae and adults, induced by interference with O-GlcNAc cy-
cling. In third instar larvae, knockdown of Ogt significantly
decreased body size (12%) compared with control strains,
whereas knockdown of Oga or overexpression of Ogt signifi-
cantly increased the body size (11 and 12%, respectively)
(Fig. 1, A and B). The adult flies exhibited a similar modula-
tion in body size (Fig. 1, C and D). These results demonstrate
that altering O-GlcNAc cycling in the IPCs influences body
size and suggests changes in DILP levels.
O-GlcNAc Cycling Modulates DILP Expression—DILP2,
DILP3, and DILP5 are expressed in the IPCs, and the levels of
these peptides modulate growth and body size (33). Given the
changes in body size that we detected in response to
O-GlcNAc perturbation in the IPCs, we wanted to determine
whether changes in O-GlcNAc cycling correlated with DILP
levels. We measured dilp2, dilp3, and dilp5 transcripts by
quantitative real time PCR using total RNA from wandering
third instar larvae. Knockdown of Ogt decreased dilp2, dilp3,
and dilp5 transcript levels compared with control (60, 26,
and 26%, respectively), whereas knockdown of Oga in-
creased expression levels for all three dilps (28, 55,
and 57%, respectively) (Fig. 2A).
DILP2 protein expression in the brain of third instar larvae
was evaluated using a DILP2-specific antibody. DILP2 stain-
ing decreased with the knockdown of Ogt (Fig. 2B, OGT-
FIGURE 1. Altered O-GlcNAc cycling influences Drosophila body size. Third instar larvae or 4-day-old adults of dILP2GAL4/;UAS-dOGTRNAi/
(OGT-RNAi), dILP2GAL4/;UAS-dOGARNAi/ (OGA-RNAi), dILP2GAL4/;UAS-myc-dOGT/ (OGT-Myc), or control strains were collected. A, measure-
ment of larval size. Data are expressed as the means  S.E. (n  20). *, p  0.05 versus control. B, representative images of third instar larvae are
shown. C, body weight measurement of adult flies. Data are expressed as the means  S.E. (n  25). *, p  0.05 versus control. D, representative im-
ages of adult flies are shown.
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RNAi) and increased with the knockdown of Oga (Fig. 2B,
OGA-RNAi) compared with control. The targeted knockdown
of Ogt or Oga was not toxic to the IPCs. TUNEL assay and
DAPI staining of the nuclei did not reveal changes in chroma-
tin structure that would be consistent with apoptosis or ne-
crosis (Fig. 3). Additionally, the morphology of IPCs did not
change with RNAi of O-GlcNAc cycling enzymes. These re-
sults suggest that deregulation of O-GlcNAc cycling induced
by knockdown of either enzyme significantly altered DILP
expression in the absence of overt toxicity to the IPCs.
Both Knockdown Models of O-GlcNAc Cycling Increase He-
molymph Carbohydrate Levels—Insects contain two types of
carbohydrate in circulating hemolymph: glucose and treha-
lose. The DILPs play an important role in regulating the levels
of these circulating carbohydrates. To understand the role of
altering DILP levels in this process, hemolymph carbohydrate
levels for each strain were evaluated by high performance an-
ion exchange-pulse amperometric detector. We have used
this method to measure carbohydrate levels in C. elegans (19,
20). An example of the separation profile illustrating the clear
resolution of trehalose and glucose is shown (Fig. 4A, peaks 1
and 2, respectively). In both third instar larvae and adult flies,
knockdown of Ogt increased hemolymph carbohydrate levels
compared with control strains (27%, 32%, respectively)
(Fig. 4, B and C). Interestingly, knockdown of Oga corre-
lated with increased hemolymph carbohydrate levels (28
and 43%, respectively) (Fig. 4, B and C), even with in-
creased DILP levels (Fig. 2). Therefore, deregulation of
O-GlcNAc cycling by targeted knockdown of either en-
zyme in the IPCs resulted in higher circulating carbohy-
drate levels. Although higher carbohydrate levels might be
expected from the lower production of DILPs (Ogt knock-
down), the elevated carbohydrate associated with higher
DILPs expression in the Oga knockdown was surprising.
One possibility is that chronically elevated DILPs might
lead to changes in signaling in insulin-responsive tissues,
which normally take up hemolymph carbohydrate, possibly
representing a kind of insulin resistance. We have reported
previously that carbohydrate uptake and storage are per-
turbed in transgenic models with altered O-GlcNAc cy-
cling in both mice and C. elegans (13, 19, 20).
O-GlcNAc Cycling Influences the Insulin-signaling
Pathway—The insulin-signaling pathway is required for
growth and the regulation of carbohydrate metabolism in
Drosophila (34). To confirm the influence of altered
O-GlcNAc cycling in the IPCs on the insulin-signaling path-
way in the peripheral tissues, we used a Drosophila-specific
phospho-Akt (p-Akt) antibody. Previous reports have shown
that the phosphorylation site on Ser-505 in Drosophila Akt,
corresponding to Ser-473 in mammalian Akt, is activated by
extraneous insulin stimulation through the phosphatidylinosi-
tol (PI) 3-kinase pathway in Drosophila culture cells (35). In
both third instar larvae and adult flies, targeted knockdown of
FIGURE 2. Altered O-GlcNAc cycling modulates DILP expression. A, gene
expression levels of dilp2, dilp3, and dilp5 in the third instar larvae were eval-
uated by quantitative real time PCR. Control experiments were carried out
with Drosophila Actin42. Data are expressed as the means  S.E. (n  10).
Dilp levels were decreased in dILP2GAL4/;UAS-dOGTRNAi/ (OGT-RNAi)
but increased in dILP2GAL4/;UAS-dOGARNAi/ (OGA-RNAi) compared
with control. *, p  0.05; **, p  0.001 versus the control. B, third instar larval
brain was stained with rabbit anti-Drosophila insulin (DILP2) antibody.
DILP2 staining in IPCs was decreased in OGT-RNAi but increased in
OGA-RNAi.
FIGURE 3. The targeted knockdown of Ogt or Oga was not overtly toxic
to the IPCs. Third instar larval brain from dILP2GAL4/;UAS-dOGTRNAi/
(OGT-RNAi), dILP2GAL4/;UAS-dOGARNAi/ (OGA-RNAi), or control strains
was stained with rabbit anti-Drosophila insulin (DILP2) antibody. A, TUNEL
reaction was performed using an in situ cell detection kit (Roche Applied
Science) after DILP2 staining. For positive control, brain was incubated with
DNaseI for 15 min before TUNEL reaction. No staining of DNA fragmenta-
tion was seen in the strains except for the positive control (DNase ) (mid-
dle column). Staining was merged (right column) with DILP2 staining (left
column). B, DAPI staining was performed after DILP2 staining. DAPI staining
of the nuclei did not reveal changes in chromatin structure (middle column).
DAPI staining was merged (right column) with DILP2 staining (left column).
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Oga, but not knockdown of Ogt in the IPCs, increased the
level of p-Akt compared with control (35 and 29%, re-
spectively) (Fig. 5, A and B). These results suggest that alter-
ing O-GlcNAc cycling in the IPCs affects the insulin-signaling
pathway in peripheral tissues in a manner consistent with
persistent elevated circulating DILP levels.
Extraneous Insulin Response Is Impaired in the Dissected
Fat Body—In insects, the fat body is responsible for the up-
take of hemolymph carbohydrate and for modulating energy
storage (32). DILPs, in part, regulate carbohydrate uptake by
the fat body. We examined the effect of extraneous insulin
administration in ex vivo cultured fat bodies from third instar
larvae using an established protocol (32). Fat bodies were dis-
sected and cultured and then treated with 1 g/ml of insulin
for 15 min. We then evaluated the response in the insulin-
signaling pathway using Western blot analysis with a p-Akt
antibody. Under basal conditions (Fig. 5C, Insulin ()), p-Akt
was not detectable in any of the strains, although equivalent
amounts of Akt were present as demonstrated using a pan-
Akt antibody (Fig. 5C, Akt). In the control strain, insulin dra-
matically increased the level of p-Akt. However, the level of
p-Akt was significantly less when either Ogt or Oga were
knocked down in the IPCs (41 and 42%, respectively) (Fig.
5C, Insulin ()). Intriguingly, both elevation of DILPs by Oga
knockdown and reduction in DILPs by Ogt knockdown lead
to a reduction in insulin responsiveness in this target tissue.
These results confirm that modulating O-GlcNAc cycling in
the IPCs diminishes the acute response to insulin in the pe-
ripheral tissues.
Previously, we have demonstrated that disrupted
O-GlcNAc cycling alters insulin signaling in the worm and
mouse (13, 19, 20). This phenomenon has also been observed
in tissue culture models of insulin resistance. To more di-
rectly examine the role of O-GlcNAc cycling in peripheral
tissues of the fly, we directed Oga and Ogt knockdown in the
fat body using the Lsp2-GAL4 fat body-specific driver strain
and examined neutral lipid storage (Fig. 6A). As shown in Fig.
6B, knockdown of either enzyme of O-GlcNAc cycling dra-
matically reduced the accumulation of neutral lipids in the fat
body. Accompanying these macronutrient storage changes
were alterations in the levels of several lipogenic and lipolytic
enzymes including acetyl-CoA carboxylase, fatty acid syn-
thase, lipase 4, and carnitine palmitoyltransferase I (supple-
mental Figs. S1 and S2). These transcriptional changes dif-
fered between starved (supplemental Fig. S1) and fed flies
(supplemental Fig. S2), with Ogt knockdown having a greater
effect in starvation, and the Oga knockdown producing more
striking effects upon feeding. Taken together, these findings
suggest that O-GlcNAc plays a role in mediating the response
to nutrient flux in a peripheral tissue involved in fat storage;
this function may complement its role in regulating insulin
production in IPCs in response to nutrients. This suggests
that deregulation of O-GlcNAc cycling could contribute to
both altered insulin production and insulin signaling in pe-
ripheral tissues in a manner reminiscent of mammalian insu-
lin resistance.
DISCUSSION
Here we show that targeted disruption of O-GlcNAc cy-
cling in the IPCs modulates the production of the DILPs.
These perturbations are associated with profound changes in
body size and growth, as well as insulin sensing in target tis-
sue. These phenotypes suggest that IPCs are acutely sensitive
to alterations in O-GlcNAc cycling.
To date, a variety of model systems have been examined
with regard to the physiological role of O-GlcNAc cycling. In
plants, the two OGT homologs Spindly and Secret Agent ap-
pear to play key roles in development (5, 6). The OGT knock-
out in mice produces stem cell and embryonic lethality; the
conditional knock-outs survive only until embryonic day 5.5
(16). We have previously shown that C. elegans null alleles of
OGT and OGA were viable and fertile with changes in insu-
lin-like signaling (19, 20). More recently we have used these
mutants to evaluate the dynamic cycling of O-GlcNAc at pro-
moters of genes involved in longevity, the stress response, and
pathogen resistance. These genes become deregulated in the
FIGURE 4. Elevated hemolymph carbohydrate concentration in transgenic flies with altered O-GlcNAc cycling. A, hemolymph carbohydrate levels
were determined by high performance anion exchange-pulse amperometric detector. The peaks represent trehalose (peak 1) and glucose (peak 2). Peak 3
indicates a nonspecific peak. B and C, hemolymph was collected from wandering third instar larvae (B) and 4-day-old adult flies starved for 6 h (C). Trehalose
and glucose concentration in dILP2GAL4/;UAS-dOGTRNAi/ (OGT-RNAi), dILP2GAL4/;UAS-dOGARNAi/ (OGA-RNAi), or control were measured. Data are
expressed as the means  S.E. (third instar larvae; n  8, adults; n  10). Both OGT-RNAi and OGA-RNAi increased carbohydrate levels. *, p  0.05 versus the
control.
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mutants leading to changes in longevity, dauer, and stress
(37). The differences observed between the phenotypes in
mammals and nematodes are likely due to the importance of
O-GlcNAc cycling in early development. Thus, it has become
important to examine the role of O-GlcNAc cycling more
broadly, to define its role as a nutrient-sensing post-transla-
tional modification.
O-GlcNAc Cycling in Drosophila—In Drosophila, ogt/Sxc
(CG10392) and oga (CG5871) are highly similar to the mam-
malian ncOGT and OGA genes, respectively. We have previ-
ously examined the results of Ogt/Sxc knockdown in Drosoph-
ila S2 cells (22). In addition, recent studies have linked Ogt/
Sxc to the regulation of homeotic gene expression in
Drosophila (23, 24). Therefore, Drosophila has emerged as a
genetically amenable and convenient model system for evalu-
ating the physiological role of O-GlcNAc.
In our current studies, perturbation of Drosophila
O-GlcNAc cycling in IPCs by GAL4UAS-RNAi results in
the deregulation of Dilp production and increases in circulat-
ing carbohydrate levels in the hemolymph. These changes are
not unlike the phenotypes of diabetes mellitus in mammals.
We demonstrated that fly strains were still viable even with
the targeted overexpression of Ogt or the knockdown of Ogt
or Oga in DILP2-expressing cells. The generation of viable
FIGURE 5. Endogenous insulin signaling in the peripheral tissues and response of extraneous insulin stimulation in dissected fat bodies. A and
B, bodies of wandering third instar larvae (A) and 4-day-old adult flies (B) in dILP2GAL4/; UAS-dOGTRNAi/ (OGT-RNAi), dILP2GAL4/; UAS-dOGARNAi/
(OGA-RNAi), or control were homogenized. C, fat bodies of OGT-RNAi, OGA-RNAi, or control were dissected and incubated for 4 h, and then 1 g/ml of insu-
lin was administrated in the medium and cultured for another 15 min. Western blot analysis was performed using Drosophila-specific phospho-Akt (p-Akt)
antibody (Ser-505) and Akt antibody. Intensity of p-Akt was normalized by intensity of Akt. Data are expressed as the means  S.E. (A, n  8; B, n  7;
C, n  7). The endogenous p-Akt level was higher in OGA-RNAi, but the level of p-Akt in the cultured insulin stimulation was less in both OGT-RNAi
and OGA-RNAi. *, p  0.05; **, p  0.001 versus the control.
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transgenic Drosophila strains overexpressing or depleting Ogt
or Oga activity in discrete tissues allows a direct examination
of the role that the O-GlcNAc modification may play in the
metabolism and physiology of the fly.
O-GlcNAc Cycling Modulates Insulin Production in Dro-
sophila Insulin-producing Cells—Previous studies suggested
that in mammalian pancreatic -cells, insulin expression and
secretion might be linked to the hexosamine-signaling path-
way. Transgenic mice overexpressing glutamine:fructose-6-
phosphate amidotransferase, the rate-limiting enzyme for
hexosamine-signaling pathway, in the pancreas exhibit in-
creased insulin content in pancreatic islets and associated
hyperinsulinemia (38). It has been shown that glucose-in-
duced transient hyperglycemia in rats resulted in a corre-
sponding transient increase in O-GlcNAc protein levels in
pancreatic -cells (39). Moreover, in the MIN6 -cell line,
depletion of OGT using siRNA markedly inhibited glucose-
induced insulin release (40). These reports strongly suggest
that glucose-stimulated insulin production may be modulated
by the O-GlcNAc modification. The Drosophila genome con-
tains seven dilp genes. Previous studies have shown that the
expression of UAS-rpr by the IPCs-specific driver, dILP2-
GAL4, decreased dilp2, dilp3, and dilp5 gene expression (28,
33). Additionally, deletion of dilps1–5 decreased body size
and elevated carbohydrate levels (30). In our study, targeting
only Ogt or Oga by RNAi modulated dilp2, dilp3, and dilp5
gene expression and altered body size, without overt changes
in IPC viability. These results support the notion that
O-GlcNAc modification is a key modulator for DILP produc-
tion and release by Drosophila IPCs.
Deregulation of Carbohydrate Metabolism: The Fly as a
Model of Glucose Toxicity?—The Drosophila fat body is re-
sponsible for the uptake of hemolymph carbohydrate and for
modulating energy storage (32). Previous reports have shown
that either ablation of IPCs or deletion of dilps in Drosophila
induces elevated carbohydrate levels in the hemolymph (28–
30). In mammals, insulin regulates the blood glucose level via
translocation of GLUT4, the glucose transporter, to the
plasma membrane in the insulin-responsive tissues. This
mechanism is mediated through the PI3-kinase/Akt signaling
pathway. The insulin-signaling pathway in Drosophila is
highly conserved and similar to the mammalian insulin-sig-
naling pathway (25, 31). PI3-kinase/Akt signaling in Drosoph-
ila peripheral tissues is required for growth. Overexpression
of PTEN, the negative regulator of PI3-kinase, inhibited fly
body size (41).
The role of O-GlcNAc cycling in insulin-glucose-homeo-
stasis is more complex. In our studies, knockdown of Oga in
the IPCs increased the endogenous activation of Akt in vivo;
this was expected to occur given the elevation of insulin ex-
pression and increased body size. However, this strain also
showed increased hemolymph carbohydrate levels similar to
that seen with knockdown of Ogt in the IPCs. Both knock-
down of Ogt and of Oga in the IPCs diminished the activation
of Akt by extraneous acute insulin administration in the ex
vivo cultured fat body. Although the mechanism of induction
of this altered insulin response in the Drosophila peripheral
tissues is not clear, these results suggest that both strains ex-
hibit a reduction in the responsiveness of the insulin-signaling
pathway. This pathway is known to be required for glucose
uptake into peripheral tissues, such as the fat body.
Relationship between Fly and Mammalian Glucose
Homeostasis—Diabetes in mammals involves altered insulin
secretion in the pancreatic -cell and peripheral insulin re-
sistance. In mammals, insulin resistance causes impaired glu-
cose tolerance and hyperglycemia because of reduction of
glucose uptake via GLUT4 translocation mediated through
impairment PI3-kinase/Akt signaling pathway (42, 43). Hy-
perglycemia is responsible for insulin resistance, mediated by
several factors, such as oxidative stress, cytokine activation,
and mitochondrial dysfunction. Some reports suggest that
sustained hyperinsulinemia may also lead to insulin resistance
(44, 45). Pirola et al. (46) reported that prolonged insulin
treatment on L6 myoblasts desensitized PI3-kinase and insu-
lin-induced glucose uptake. Egawa et al. (47) reported that
persistent activation of PI3-kinase leads to desensitization of
insulin action in 3T3-L1 adipocytes. Hyperglycemia then
causes compensation of insulin production and deterioration
of insulin resistance, ultimately leading to deregulation of in-
sulin production. This vicious circle is known as glucose tox-
icity, which is essential in the progression of type 2 diabetes
(36). Our results suggest that inhibition of O-GlcNAc levels
by knockdown of Ogt in the IPCs induces hyperglycemia be-
cause of impairment of insulin production. Continuous in-
FIGURE 6. Tissue-specific knockdown of ogt/sxc or oga alters lipid accumulation in the fat body. A, schematic representation of experimental design
where third instar larval fat bodies were dissected from Lsp2GAL4/;UAS-dOGTRNAi/ (OGT-RNAi), Lsp2GAL4/;UAS-dOGARNAi/ (OGA-RNAi), or control
strains and the triglyceride content measured by a coupled assay. B, triglyceride content is expressed as a relative percentage to the control strain.
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creases in O-GlcNAcylation by knockdown of Oga in the IPCs
mimic the compensation of insulin production for chronic
hyperglycemic phenomena related to glucose toxicity.
Summary and Conclusions—In human genetic studies, a
single nucleotide polymorphism in intron 10 of the MEGA5
gene encoding OGA is associated with diabetes mellitus and
age of onset in the Mexican-American population. This poly-
morphism may interfere with OGA activity in the susceptible
population (14). This report strongly suggests a possible rela-
tionship between polymorphisms in the human OGA gene
and pancreatic -cell function and insulin resistance in the
peripheral tissues.
In our studies, deregulation of O-GlcNAc cycling inDrosoph-
ila insulin-producing cells produces a phenotype with striking
parallels to human diabetes. The enzymes of O-GlcNAc cycling
appear to act by “fine-tuning” the insulin production systems,
providing additional levels of metabolic control in response to
nutrient availability. This fine-tuningmechanism is likely to ap-
ply to other proposed functions of O-GlcNAc cycling inDro-
sophila, which include insulin signaling-regulatedmetabolic
modulation in the fat body and other peripheral tissues.We
found that specific knockdown of bothOgt andOga in the fat
body altered triglyceride levels (Fig. 6). This was associated with
changes in gene expression of a number of lipolytic and lipogenic
enzymes. These findings mirror observations we have previously
made with null alleles of the enzymes of O-GlcNAc cycling inC.
elegans (19, 20, 37).We conclude that the insect may be a very
useful model for examining the production of insulin-like pep-
tides in the insulin-producing cells induced by nutrient-sensitive
perturbations in O-GlcNAc cycling. Alterations in this cycling
may result in glucose toxicity and altered responsiveness of pe-
ripheral tissues to the normal metabolic regulation by insulin.
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